<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Aviva Plc — News on 6ix</title>
<link>https://6ix.com/company/aviva-plc</link>
<description>Latest news and press releases for Aviva Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 24 Apr 2026 14:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/aviva-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d57935beedb30cb6f88077.webp</url>
<title>Aviva Plc</title>
<link>https://6ix.com/company/aviva-plc</link>
</image>
<item>
<title>Admission to Trading</title>
<link>https://6ix.com/company/aviva-plc/news/admission-to-trading-34</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/admission-to-trading-34</guid>
<pubDate>Fri, 24 Apr 2026 14:00:00 GMT</pubDate>
<description>Aviva plc has announced the admission of 413,942 new Ordinary Shares to trading on the London Stock Exchange's Main Market, issued under various share schemes. These new shares are fully fungible with existing ordinary shares, bringing the total number of shares admitted to trading to 3,028,937,203. The admission of these shares occurred between January 1, 2026, and April 23, 2026.
Disclaimer*</description>
</item>
<item>
<title>Transaction in Own Shares</title>
<link>https://6ix.com/company/aviva-plc/news/transaction-in-own-shares-689</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/transaction-in-own-shares-689</guid>
<pubDate>Fri, 17 Apr 2026 06:00:00 GMT</pubDate>
<description>Aviva plc has announced the purchase of 776,228 of its own ordinary shares on 16 April 2026, with prices ranging from 638.80 pence to 649.60 pence, and a volume-weighted average price of 643.28 pence. These shares will be cancelled as part of the company's ongoing buy-back programme. Following this transaction and cancellation, Aviva will have 3,029,643,075 ordinary shares in issue, which shareholders can use as a denominator for regulatory notification calculations.
Disclaimer*</description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/aviva-plc/news/directorpdmr-shareholding-847</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/directorpdmr-shareholding-847</guid>
<pubDate>Thu, 16 Apr 2026 13:30:00 GMT</pubDate>
<description>Aviva plc has announced transactions by several Persons Discharging Managerial Responsibilities (PDMRs) involving ordinary shares. On April 15, 2026, Douglas Brown, James Hillman, Mark Versey, and Jason Storah acquired shares under the Aviva All Employee Share Ownership Plan at £6.39 per share, with Brown, Hillman, and Versey each purchasing 40 shares, and Storah purchasing 32 shares. Navinder Dhillon acquired 62 shares at £6.34 each under the Aviva Global Matching Share Plan, and Pippa Lambert </description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/aviva-plc/news/total-voting-rights-888</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/total-voting-rights-888</guid>
<pubDate>Wed, 01 Apr 2026 15:00:00 GMT</pubDate>
<description>Aviva plc has announced its total voting rights as of March 31, 2026. The company had 3,050,244,929 ordinary shares issued and admitted to trading, with each share carrying one vote. Following the purchase of 6,720,847 ordinary shares under its share buyback program, which are subject to cancellation, the total number of voting rights in Aviva plc is now 3,043,524,082. This figure will serve as the denominator for shareholders calculating their notification requirements under the FCA's Disclosur</description>
</item>
<item>
<title>Notice of AGM</title>
<link>https://6ix.com/company/aviva-plc/news/notice-of-agm-597</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/notice-of-agm-597</guid>
<pubDate>Mon, 30 Mar 2026 09:00:00 GMT</pubDate>
<description>Aviva plc has announced the availability of its Notice of 2026 Annual General Meeting and Form of Proxy, which are being mailed to shareholders along with the 2025 Annual Report and Accounts. The AGM will take place on Wednesday, May 6, 2026, at 9am at Aviva's York office, with electronic attendance options provided. These documents are also accessible on the company's website and have been submitted to the National Storage Mechanism.
Disclaimer*</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/aviva-plc/news/holdings-in-company-1181</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/holdings-in-company-1181</guid>
<pubDate>Fri, 27 Mar 2026 14:00:00 GMT</pubDate>
<description>Aviva PLC has notified Tate & Lyle PLC of a change in its holdings, specifically due to shares being loaned out. As of March 26, 2026, Aviva PLC's total voting rights and financial instruments in Tate & Lyle PLC amount to 3.64%, comprising 2.96% directly held shares and 0.68% through financial instruments related to the right to recall loaned shares. This represents a decrease in direct interest from a previous notification.
Disclaimer*</description>
</item>
<item>
<title>Publication of updated Euro Note Prospectus</title>
<link>https://6ix.com/company/aviva-plc/news/publication-of-updated-euro-note-prospectus</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/publication-of-updated-euro-note-prospectus</guid>
<pubDate>Wed, 11 Mar 2026 14:16:00 GMT</pubDate>
<description>Aviva plc has published an updated Euro Note Programme Prospectus dated 11 March 2026, which has been approved by the Financial Conduct Authority. This annual update pertains to Aviva plc's £7,000,000,000 Euro Note Programme, which allows for the issuance of various debt instruments, including hybrid securities. The prospectus has been submitted to the National Storage Mechanism and is available for inspection.
Disclaimer*</description>
</item>
<item>
<title>Buyback of Ordinary Shares</title>
<link>https://6ix.com/company/aviva-plc/news/buyback-of-ordinary-shares</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/buyback-of-ordinary-shares</guid>
<pubDate>Thu, 05 Mar 2026 07:01:00 GMT</pubDate>
<description>Aviva plc has announced a share buyback programme of its ordinary shares for up to a maximum aggregate consideration of £350 million, commencing on March 6, 2026, and expected to conclude by August 6, 2026. The company has engaged Citigroup Global Markets Limited to execute market purchases of shares, which will subsequently be cancelled to reduce Aviva's share capital. This programme operates under Aviva's general authority to repurchase shares and complies with relevant market regulations.
</description>
</item>
<item>
<title>Notification of Major Holdings</title>
<link>https://6ix.com/company/aviva-plc/news/notification-of-major-holdings-209</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/notification-of-major-holdings-209</guid>
<pubDate>Mon, 23 Feb 2026 13:31:00 GMT</pubDate>
<description>Aviva PLC has notified Rosebank Industries PLC of a change in its major holding, specifically the return of loaned shares. As of February 19, 2026, Aviva PLC's total voting rights and financial instruments in Rosebank Industries PLC amount to 3.69%, comprising 3.01% directly attached to shares and 0.68% through financial instruments, representing a total of 15,013,657 voting rights. This change is due to an increase in direct voting rights from 2.64% to 3.01%.
Disclaimer*</description>
</item>
<item>
<title>Block listing Interim Review</title>
<link>https://6ix.com/company/aviva-plc/news/block-listing-interim-review-318</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/block-listing-interim-review-318</guid>
<pubDate>Wed, 14 Jan 2026 12:00:00 GMT</pubDate>
<description>Aviva plc has provided a six-monthly return for its various share schemes covering the period from July 1, 2025, to December 31, 2025. The total balance of unallotted securities across all schemes at the end of the period is 32,363,421. Notably, the Global Matching Share Plan saw an increase of 2,000,000 securities, while 671,492 securities were issued under this plan and 6,818 under the Aviva Savings Related Share Option Scheme 2017. The remaining schemes had no increases or issuances during th</description>
</item>
<item>
<title>Update on Direct Line Capital Model</title>
<link>https://6ix.com/company/aviva-plc/news/update-on-direct-line-capital-model</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/update-on-direct-line-capital-model</guid>
<pubDate>Mon, 05 Jan 2026 15:00:00 GMT</pubDate>
<description>Aviva plc has received approval from the PRA to revoke Direct Line's Solvency II partial internal model, allowing Direct Line's capital requirements to be calculated using the standard formula from December 31, 2025. This change is expected to realize approximately £0.1 billion in capital synergies by the end of 2025, contributing about 2 percentage points to Aviva's full-year Group shareholder solvency ratio. The company anticipates further capital synergies exceeding £0.5 billion by the end of</description>
</item>
<item>
<title>Block listing Application</title>
<link>https://6ix.com/company/aviva-plc/news/block-listing-application-150</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/block-listing-application-150</guid>
<pubDate>Fri, 12 Dec 2025 07:00:00 GMT</pubDate>
<description>Aviva plc has submitted an application for a block listing of 2,000,000 ordinary shares, each with a nominal value of 32 17/19 pence, to be admitted to the Official List and trading on the London Stock Exchange's Main Market, with admission expected on December 15, 2025. These new shares will be issued to fulfill awards under the company's Global Matching Share Plan and will rank equally with existing ordinary shares upon issuance.
Disclaimer*</description>
</item>
<item>
<title>Notice of Redemption</title>
<link>https://6ix.com/company/aviva-plc/news/notice-of-redemption-17</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/notice-of-redemption-17</guid>
<pubDate>Mon, 08 Dec 2025 11:00:00 GMT</pubDate>
<description>Aviva plc has announced the full redemption of its €900,000,000 3.375 per cent. Dated Tier 2 Fixed to Floating Rate Notes, with the listing on the London Stock Exchange cancelled effective December 8, 2025. This action was taken on December 4, 2025, in accordance with the terms and conditions of the notes.
Disclaimer*</description>
</item>
<item>
<title>In Focus and Q3 2025 Trading Update</title>
<link>https://6ix.com/company/aviva-plc/news/in-focus-and-q3-2025-trading-update</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/in-focus-and-q3-2025-trading-update</guid>
<pubDate>Thu, 13 Nov 2025 07:00:00 GMT</pubDate>
<description>Aviva plc has released its In Focus and Q3 2025 Trading Update for the nine-month period ended 30 September 2025, with total Group assets under management reaching £419 billion as of 30 June 2025 and an estimated Solvency II shareholder capital surplus of £7.0 billion as of 30 September 2025. The company also noted that it paid £29.3 billion in claims and benefits to its customers in 2024.
Disclaimer*</description>
</item>
<item>
<title>Standard form for notification of major holdings</title>
<link>https://6ix.com/company/aviva-plc/news/standard-form-for-notification-of-major-holdings-68</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/standard-form-for-notification-of-major-holdings-68</guid>
<pubDate>Thu, 23 Oct 2025 15:33:00 GMT</pubDate>
<description>Aviva PLC has crossed a threshold related to Tritax Big Box REIT PLC on October 22, 2025, and notified the issuer on October 23, 2025. Aviva PLC's voting rights attached to shares decreased to 2.99%, representing 80,829,365 voting rights. This is a change from the previous notification, where the percentage of voting rights attached to shares was 3.89%. The change is prompted by a shift at the direct interest level. The total of voting rights through financial instruments remains at 0.00%.
</description>
</item>
<item>
<title>Publication of Supplementary Prospectus</title>
<link>https://6ix.com/company/aviva-plc/news/publication-of-supplementary-prospectus-42</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/publication-of-supplementary-prospectus-42</guid>
<pubDate>Fri, 15 Aug 2025 11:00:00 GMT</pubDate>
<description>Publication of Supplementary Prospectus.</description>
</item>
<item>
<title>2025 Interim Results Announcement</title>
<link>https://6ix.com/company/aviva-plc/news/2025-interim-results-announcement-3</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/2025-interim-results-announcement-3</guid>
<pubDate>Thu, 14 Aug 2025 06:00:00 GMT</pubDate>
<description>2025 Interim Results Announcement.</description>
</item>
<item>
<title>Listing Application</title>
<link>https://6ix.com/company/aviva-plc/news/listing-application-7</link>
<guid isPermaLink="true">https://6ix.com/company/aviva-plc/news/listing-application-7</guid>
<pubDate>Mon, 21 Jul 2025 11:30:00 GMT</pubDate>
<description>Listing Application.</description>
</item>
</channel>
</rss>